4.7 Review

The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator

期刊

CANCER LETTERS
卷 356, 期 2, 页码 165-170

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.01.018

关键词

AMPK; Tumor metabolism; mTOR; Warburg effect; HIF-1 alpha

类别

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. McGill Integrated Cancer Research Training Program (MICTRP)
  3. CIHR [MOP-93799]
  4. Canadian Cancer Society [2010-700586]
  5. Terry Fox Research Foundation [TEF-116128]

向作者/读者索取更多资源

The AMP-activated protein kinase (AMPK) is a central regulator of cellular metabolism and energy homeostasis in mammalian tissues. Pertinent to cancer biology is the fact that AMPK is situated in the center of a signaling network involving established tumor suppressors including LKB1, TSC2 and p53. However, recent- research suggests that AMPK can exert pro- or anti-tumorigenic roles in cancer depending on context. Loss of AMPK activity has been observed in several tumor types, and can cooperate with oncogenic drivers to reprogram tumor cell metabolism and enhance cell growth and proliferation. However, AMPK activation can also provide a growth advantage to tumor cells by regulating cellular metabolic plasticity, thus providing tumor cells the flexibility to adapt to metabolic stress. Here we discuss the contextual nature of the two faces of AMPK in cancer, and discuss the rationale and context for employing AMPK activators versus inhibitors for cancer therapy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据